[HTML][HTML] Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature

MS Cattaruzza, V Zagà, S Gallus… - Acta Bio Medica …, 2020 - ncbi.nlm.nih.gov
Methods: articles from MEDLINE and pre-prints published from January to April 2020 were
identified. Results: data from China showed that men had more severe outcomes of COVID …

Association between smoking, e-cigarette use and severe COVID-19: a cohort study

M Gao, P Aveyard, N Lindson… - International Journal …, 2022 - academic.oup.com
Background Smoking is a risk factor for most respiratory infections, but it may protect against
SARS-CoV-2 infection. The objective was to assess whether smoking and e-cigarette use …

Exposure to health misinformation about COVID-19 and increased tobacco and alcohol use: a population-based survey in Hong Kong

TT Luk, S Zhao, X Weng, JYH Wong, YS Wu… - Tobacco …, 2021 - tobaccocontrol.bmj.com
Introduction Health information about COVID-19 has been circulating in social networking
sites, including unproven claims that smoking and alcohol drinking could protect against …

[HTML][HTML] Microglial implications in SARS-CoV-2 infection and COVID-19: Lessons from viral RNA neurotropism and possible relevance to Parkinson's disease

IO Awogbindin, B Ben-Azu, BA Olusola… - Frontiers in Cellular …, 2021 - frontiersin.org
Since December 2019, humankind has been experiencing a ravaging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, the second coronavirus …

[HTML][HTML] Tobacco use as a well-recognized cause of severe COVID-19 manifestations

AK Gupta, ST Nethan, R Mehrotra - Respiratory Medicine, 2021 - Elsevier
Abstract Introduction The Coronavirus disease (COVID-19) infection is caused by the novel
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) primarily affecting the …

PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking

C Lugnier, HM Al-Kuraishy, E Rousseau - Biochemical Pharmacology, 2021 - Elsevier
Abstract Angiotensin-converting enzyme 2 (ACE2) is the binding-site and entry-point for
SARS-CoV-2 in human and highly expressed in the lung. Cigarette smoking (CS) is the …

A systematic review and meta-analysis of hospitalised current smokers and COVID-19

J González-Rubio, C Navarro-López… - International Journal of …, 2020 - mdpi.com
SARS-CoV-2 is a new coronavirus that has caused a worldwide pandemic. It produces
severe acute respiratory disease (COVID-19), which is fatal in many cases, characterised by …

Ivermectin as a broad-spectrum host-directed antiviral: the real deal?

DA Jans, KM Wagstaff - Cells, 2020 - mdpi.com
The small molecule macrocyclic lactone ivermectin, approved by the US Food and Drug
Administration for parasitic infections, has received renewed attention in the last eight years …

Tobacco and COVID-19: a crisis within a crisis?

F Alla, I Berlin, V Nguyen-Thanh, R Guignard… - Canadian Journal of …, 2020 - Springer
During the pandemic, the world's media have publicized preliminary findings suggesting that
tobacco use is protective against COVID-19. An ad hoc multidisciplinary group was created …

Tobacco, alcohol use and other risk factors for developing symptomatic COVID-19 vs asymptomatic SARS-CoV-2 infection: a case–control study from western …

S Saurabh, MK Verma, V Gautam… - Transactions of The …, 2021 - academic.oup.com
Background Understanding risk factors of symptomatic coronavirus disease 2019 (COVID-
19) vis-à-vis asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …